0001127602-20-005477.txt : 20200214
0001127602-20-005477.hdr.sgml : 20200214
20200214122448
ACCESSION NUMBER: 0001127602-20-005477
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200213
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERTOLINI ROBERT J
CENTRAL INDEX KEY: 0001270263
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 20616765
MAIL ADDRESS:
STREET 1: C/O SCHERING PLOUGH CORP
STREET 2: 2000 GALLOPING HILL RD
CITY: KENILWORTH
STATE: NJ
ZIP: 070333
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-02-13
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001270263
BERTOLINI ROBERT J
CHARLES RIVER LABORATORIES
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
Common Stock
2020-02-13
4
M
0
4030
43.39
A
31905
D
Common Stock
2020-02-13
4
M
0
3140
70.29
A
35045
D
Common Stock
2020-02-13
4
S
0
7170
170.4071
D
27875
D
Stock Options (Right to Buy)
43.39
2020-02-13
4
M
0
4030
0
D
2014-05-08
2020-05-08
Common Stock
4030
0
D
Stock Options (Right to Buy)
70.29
2020-02-13
4
M
0
3140
0
D
2016-05-06
2020-05-06
Common Stock
3140
0
D
This transaction was executed in multiple trades at prices ranging from $169.925 to $170.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Robert J. Bertolini
2020-02-14